Novavax

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novavax and other ETFs, options, and stocks.

About NVAX

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. 

CEO
John C.s Jacobs
CEOJohn C.s Jacobs
Employees
1,543
Employees1,543
Headquarters
Gaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded
1987
Founded1987
Employees
1,543
Employees1,543

NVAX Key Statistics

Market cap
1.17B
Market cap1.17B
Price-Earnings ratio
-3.17
Price-Earnings ratio-3.17
Dividend yield
Dividend yield
Average volume
4.18M
Average volume4.18M
High today
$7.44
High today$7.44
Low today
$7.17
Low today$7.17
Open price
$7.22
Open price$7.22
Volume
3.93M
Volume3.93M
52 Week high
$23.86
52 Week high$23.86
52 Week low
$3.81
52 Week low$3.81

NVAX News

Simply Wall St 2d
Breakeven Is Near for Novavax, Inc.

With the business potentially at an important milestone, we thought we'd take a closer look at Novavax, Inc.'s ( ) future prospects. Novavax, Inc., a biotechnol...

Breakeven Is Near for Novavax, Inc.
TipRanks 2d
Novavax: Promising Innovations Amidst Execution and Competitive Challenges – Hold Rating

TD Cowen analyst Steve Scala maintained a Hold rating on Novavax (NVAX – Research Report) today and set a price target of $9.00. Steve Scala has given his Hold...

TipRanks 5d
Novavax call volume above normal and directionally bullish

Bullish option flow detected in Novavax (NVAX) with 23,789 calls trading, 3x expected, and implied vol increasing over 8 points to 114.25%. Feb-25 8.5 calls and...

Analyst ratings

50%

of 6 ratings
Buy
50%
Hold
33.3%
Sell
16.7%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.